402 related articles for article (PubMed ID: 19567784)
1. Omega-3 polyunsaturated fatty acids down-modulate CXCR4 expression and function in MDA-MB-231 breast cancer cells.
Altenburg JD; Siddiqui RA
Mol Cancer Res; 2009 Jul; 7(7):1013-20. PubMed ID: 19567784
[TBL] [Abstract][Full Text] [Related]
2. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
3. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
[TBL] [Abstract][Full Text] [Related]
4. CD24 affects CXCR4 function in pre-B lymphocytes and breast carcinoma cells.
Schabath H; Runz S; Joumaa S; Altevogt P
J Cell Sci; 2006 Jan; 119(Pt 2):314-25. PubMed ID: 16390867
[TBL] [Abstract][Full Text] [Related]
5. Complementary actions of docosahexaenoic acid and genistein on COX-2, PGE2 and invasiveness in MDA-MB-231 breast cancer cells.
Horia E; Watkins BA
Carcinogenesis; 2007 Apr; 28(4):809-15. PubMed ID: 17052999
[TBL] [Abstract][Full Text] [Related]
6. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
7. Chemical-physical changes in cell membrane microdomains of breast cancer cells after omega-3 PUFA incorporation.
Corsetto PA; Cremona A; Montorfano G; Jovenitti IE; Orsini F; Arosio P; Rizzo AM
Cell Biochem Biophys; 2012 Sep; 64(1):45-59. PubMed ID: 22622660
[TBL] [Abstract][Full Text] [Related]
8. Differential functional activation of chemokine receptor CXCR4 is mediated by G proteins in breast cancer cells.
Holland JD; Kochetkova M; Akekawatchai C; Dottore M; Lopez A; McColl SR
Cancer Res; 2006 Apr; 66(8):4117-24. PubMed ID: 16618732
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of n-3 and n-6 polyunsaturated fatty acids on BRCA1 and BRCA2 gene expression in breast cell lines.
Bernard-Gallon DJ; Vissac-Sabatier C; Antoine-Vincent D; Rio PG; Maurizis JC; Fustier P; Bignon YJ
Br J Nutr; 2002 Apr; 87(4):281-9. PubMed ID: 12064337
[TBL] [Abstract][Full Text] [Related]
10. Transendothelial migration of two metastatic breast carcinoma cells depend on the SDF-lalpha-CXCR4 complexes.
Lechertier T; Berard M; Vassy R; Herve MA; Crepin M
Anticancer Res; 2004; 24(6):4011-7. PubMed ID: 15739262
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells.
Schley PD; Jijon HB; Robinson LE; Field CJ
Breast Cancer Res Treat; 2005 Jul; 92(2):187-95. PubMed ID: 15986129
[TBL] [Abstract][Full Text] [Related]
12. Docosahexaenoic acid alters epidermal growth factor receptor-related signaling by disrupting its lipid raft association.
Rogers KR; Kikawa KD; Mouradian M; Hernandez K; McKinnon KM; Ahwah SM; Pardini RS
Carcinogenesis; 2010 Sep; 31(9):1523-30. PubMed ID: 20525880
[TBL] [Abstract][Full Text] [Related]
13. [Role of Rho GTPase in inhibiting metastatic ability of human prostate cancer cell line PC-3 by omega-3 polyunsaturated fatty acid].
Yi L; Zhang QY; Mi MT
Ai Zheng; 2007 Dec; 26(12):1281-6. PubMed ID: 18076787
[TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic acid (omega-3) blocks voltage-gated sodium channel activity and migration of MDA-MB-231 human breast cancer cells.
Isbilen B; Fraser SP; Djamgoz MB
Int J Biochem Cell Biol; 2006; 38(12):2173-82. PubMed ID: 16931105
[TBL] [Abstract][Full Text] [Related]
15. Akt plays an important role in breast cancer cell chemotaxis to CXCL12.
Zhao M; Mueller BM; DiScipio RG; Schraufstatter IU
Breast Cancer Res Treat; 2008 Jul; 110(2):211-22. PubMed ID: 17687643
[TBL] [Abstract][Full Text] [Related]
16. Zerumbone down-regulates chemokine receptor CXCR4 expression leading to inhibition of CXCL12-induced invasion of breast and pancreatic tumor cells.
Sung B; Jhurani S; Ahn KS; Mastuo Y; Yi T; Guha S; Liu M; Aggarwal BB
Cancer Res; 2008 Nov; 68(21):8938-44. PubMed ID: 18974138
[TBL] [Abstract][Full Text] [Related]
17. Blockade of invasion and metastasis of breast cancer cells via targeting CXCR4 with an artificial microRNA.
Liang Z; Wu H; Reddy S; Zhu A; Wang S; Blevins D; Yoon Y; Zhang Y; Shim H
Biochem Biophys Res Commun; 2007 Nov; 363(3):542-6. PubMed ID: 17889832
[TBL] [Abstract][Full Text] [Related]
18. Effects of adenoviral gene transfer of C. elegans n-3 fatty acid desaturase on the lipid profile and growth of human breast cancer cells.
Ge Y; Chen Z; Kang ZB; Cluette-Brown J; Laposata M; Kang JX
Anticancer Res; 2002; 22(2A):537-43. PubMed ID: 12014621
[TBL] [Abstract][Full Text] [Related]
19. CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival.
Mirisola V; Zuccarino A; Bachmeier BE; Sormani MP; Falter J; Nerlich A; Pfeffer U
Eur J Cancer; 2009 Sep; 45(14):2579-87. PubMed ID: 19646861
[TBL] [Abstract][Full Text] [Related]
20. CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo.
Lapteva N; Yang AG; Sanders DE; Strube RW; Chen SY
Cancer Gene Ther; 2005 Jan; 12(1):84-9. PubMed ID: 15472715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
